array(3) { ["company_details"]=> array(13) { ["name"]=> string(14) "ELEKTA LIMITED" ["slug"]=> string(23) "dbe4b-gb-elekta-limited" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/03cdfb0f-1bfc-426b-afae-aad1f451dee7" ["description"]=> string(735) "At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more." ["address_street"]=> string(11) "Linac House" ["address_place"]=> string(7) "CRAWLEY" ["address_region"]=> NULL ["founding_date"]=> string(10) "1996-09-02" ["website_domain"]=> string(10) "elekta.com" ["website_url"]=> string(22) "https://www.elekta.com" ["industry_codes"]=> array(1) { [0]=> string(46) "Surgical and Medical Instruments and Apparatus" } ["employee_count"]=> int(820) ["article_count"]=> int(550) } ["articles"]=> array(5) { [0]=> array(7) { ["title_en"]=> string(44) "ELEKTA REINFORCES LEADERSHIP POSITION IN …" ["snippet_en"]=> string(240) "ELEKTA REINFORCES LEADERSHIP POSITION IN NEUROSURGERY AT AANS. PRESS RELEASE Stockholm, Sweden, April 18, 2005 World Champion Skater Scott Hamilton will speak in Elekta's booth on his treatment for a brain tumor using Gamma Knife® surgery." ["url"]=> string(116) "https://www.elekta.com/pressreleases/EC95B7B5C425E5A7/elekta-reinforces-leadership-position-in-neurosurgery-at-aans/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8a13788a-b915-484b-96a5-8fd0b54b66cb" ["source"]=> string(10) "elekta.com" ["publication_date"]=> string(10) "2021-04-16" ["categories"]=> array(1) { [0]=> string(25) "Leadership and Governance" } } [1]=> array(7) { ["title_en"]=> string(60) "Elekta Customers See Their Ideas Brought to Life at ESTRO 29" ["snippet_en"]=> string(250) "barcelona 2010-09-09 Elekta will demonstrate its continued leadership role in the technological advancement of radiation oncology at the 2010 meeting of the European Society for Therapeutic Radiology and Oncology( ESTRO) 12-16 September in Barcelona," ["url"]=> string(126) "https://www.elekta.com/press/bfdc9efd-d316-4e7b-a702-7d588f1e48c1/elekta-customers-see-their-ideas-brought-to-life-at-estro-29" ["image_url"]=> string(78) "https://images.businessradar.com/articles/15aa053a-7493-4078-88f9-e7e8ac474303" ["source"]=> string(10) "elekta.com" ["publication_date"]=> string(10) "2016-09-12" ["categories"]=> array(1) { [0]=> string(25) "Leadership and Governance" } } [2]=> array(7) { ["title_en"]=> string(76) "Elekta Technology at Work in 100 Percent of America’s Top Cancer Hospitals" ["snippet_en"]=> string(254) "Atlanta, GA 2012-08-03 U.S. News& World Report 's 2012 edition of America 's Best Hospitals reaffirms Elekta’ s leadership in the U.S. oncology market U.S. News& World Report recently issued its annual list of America’ s best hospitals, including the" ["url"]=> string(140) "https://www.elekta.com/press/860f2b26-47a9-4d6d-ad76-02f445047885/elekta-technology-at-work-in-100-percent-of-america-s-top-cancer-hospitals" ["image_url"]=> string(78) "https://images.businessradar.com/articles/57c5abe6-6bb3-4772-b8ea-d6e26612c161" ["source"]=> string(10) "elekta.com" ["publication_date"]=> string(10) "2012-08-03" ["categories"]=> array(2) { [0]=> string(10) "Litigation" [1]=> string(25) "Leadership and Governance" } } [3]=> array(7) { ["title_en"]=> string(47) "ELEKTA AND IMPAC USERS DEMONSTRATE CLINICAL …" ["snippet_en"]=> string(250) "PRESS RELEASE Stockholm, October 18, 2005 The 47th annual meeting of the American Society for Therapeutic Radiology and Oncology( ASTRO), this week in Denver, CO, USA, clearly demonstrated the Elekta Group 's leadership in clinical use and commercial" ["url"]=> string(176) "https://www.elekta.com/pressreleases/48B49820735CEACC/elekta-and-impac-users-demonstrate-clinical-advancements-at-astro-new-integrated-workflow-environment-for-igrt-introduced/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/829ed24e-604e-42c8-a730-242216cd5fb8" ["source"]=> string(10) "elekta.com" ["publication_date"]=> string(10) "2005-10-18" ["categories"]=> array(2) { [0]=> string(25) "Leadership and Governance" [1]=> string(17) "Academic Research" } } [4]=> array(7) { ["title_en"]=> string(53) "UPMC EXPANDS NEUROSURGERY LEADERSHIP BY ACQUIRING …" ["snippet_en"]=> string(251) "13-08-2004 · PRESS RELEASE. Stockholm, August 13, 2004. UPMC EXPANDS NEUROSURGERY LEADERSHIP BY ACQUIRING ELEKTA NEUROMAG® MEG SYSTEM. The University of Pittsburgh Medical Center( UPMC) in Pittsburgh, PA, USA, one of the nation 's premier providers" ["url"]=> string(131) "https://www.elekta.com/pressreleases/8662273B38C78BB7/upmc-expands-neurosurgery-leadership-by-acquiring-elekta-neuromag-meg-system/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/eb0cccdf-cc06-4c98-80be-794fc2555508" ["source"]=> string(10) "elekta.com" ["publication_date"]=> string(10) "2004-08-13" ["categories"]=> array(2) { [0]=> string(18) "Expansion & Growth" [1]=> string(25) "Leadership and Governance" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(35) } [1]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(25) } [2]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(23) } [3]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(19) } [4]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(16) } [5]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(16) } [6]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(15) } [7]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(14) } [8]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(11) } [9]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(11) } [10]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(11) } [11]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(9) } [12]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(8) } [13]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(7) } [14]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(6) } [15]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(6) } [16]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(6) } [17]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(6) } [18]=> array(2) { ["name"]=> string(25) "Leadership and Governance" ["count"]=> int(5) } [19]=> array(2) { ["name"]=> string(10) "Executives" ["count"]=> int(5) } [20]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [21]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(4) } [22]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(4) } [23]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(4) } [24]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(4) } [25]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(3) } [26]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(3) } [27]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(3) } [28]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(2) } [29]=> array(2) { ["name"]=> string(21) "Intellectual Property" ["count"]=> int(2) } } } dbe4b-gb-elekta-limited